Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q1 Loss of 14c/Share
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Cost of product revenues: 945K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of product revenues: 945K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $1.03 million versus the consensus estimate of $2.87 million.
For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
